{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:21:15Z","timestamp":1777911675443,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcf.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:46:10Z","timestamp":1693698370000},"page":"398-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and impact of human papillomavirus (HPV) in adults with cystic fibrosis: A self-reported cross-sectional Canadian survey"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-6211","authenticated-orcid":false,"given":"Christina S.","family":"Thornton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-4443","authenticated-orcid":false,"given":"Daniyal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjani","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jcf.2023.08.010_bib0001","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2023.08.010_bib0002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcf.2017.11.019","article-title":"Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: a longitudinal study using UK patient registry data","volume":"17","author":"Keogh","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.08.010_bib0003","unstructured":"Cystic Fibrosis Canada. 2021 annual data report. Accessed July 23 2023,."},{"key":"10.1016\/j.jcf.2023.08.010_bib0004","unstructured":"Cystic Fibrosis Australia. 2021 annual data report. Accessed July 23 2023,."},{"key":"10.1016\/j.jcf.2023.08.010_bib0005","unstructured":"Cystic Fibrosis Foundation. 2021 Patient Registry Annual Data Report. (2022). Accessed July 23 2023,."},{"key":"10.1016\/j.jcf.2023.08.010_bib0006","unstructured":"Cystic Fibrosis Trust: UK Cystic Fibrosis Registry 2021 Annual Data Report. Accessed July 23 2023,."},{"issue":"2","key":"10.1016\/j.jcf.2023.08.010_bib0007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/20734735.021014","article-title":"Inhaled therapy in cystic fibrosis: agents, devices and regimens","volume":"11","author":"Agent","year":"2015","journal-title":"Breathe (Sheff)"},{"issue":"3","key":"10.1016\/j.jcf.2023.08.010_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2020.12.001","article-title":"Bridging the survival gap in cystic fibrosis: an investigation of lung transplant outcomes in canada and the United States","volume":"40","author":"Stephenson","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.jcf.2023.08.010_bib0009","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.jcf.2023.08.010_bib0010","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/humrep\/dev217","article-title":"Contraceptive practices and cervical screening in women with cystic fibr'osis","volume":"30","author":"Rousset Jablonski","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jcf.2023.08.010_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejogrb.2017.12.005","article-title":"High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis","volume":"221","author":"Rousset-Jablonski","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.jcf.2023.08.010_bib0012","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.02589-13","article-title":"Immunosuppression facilitates the reactivation of latent papillomavirus infections","volume":"88","author":"Maglennon","year":"2014","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.jcf.2023.08.010_bib0013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/thoraxjnl-2021-218461","article-title":"Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients","volume":"77","author":"Thornton","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.08.010_bib0014","article-title":"Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosis","author":"Rousset-Jablonski","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2023.08.010_bib0015","article-title":"Human papillomavirus vaccines: an updated review","volume":"8","author":"Cheng","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jcf.2023.08.010_bib0016","article-title":"Human papilloma virus vaccination among female patients attending french pediatric cystic fibrosis centers","author":"Rousset-Jablonski","year":"2020","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"11","key":"10.1016\/j.jcf.2023.08.010_bib0017","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1185\/03007990903238786","article-title":"Development and psychometric properties of the HPV impact profile (HIP) to assess the psychosocial burden of HPV","volume":"25","author":"Mast","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jcf.2023.08.010_bib0018","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/1471-2458-14-739","article-title":"Human papillomavirus-related psychosocial impact of patients with genital warts In China: a hospital-based cross-sectional study","volume":"14","author":"Qi","year":"2014","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.jcf.2023.08.010_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/01674820903564440","article-title":"The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions","volume":"31","author":"Wang","year":"2010","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.jcf.2023.08.010_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jogc.2018.09.016","article-title":"A National Survey of Canadian Physicians on HPV: knowledge, barriers, and preventive practices","volume":"41","author":"Steben","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jcf.2023.08.010_bib0021","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jcf.2023.08.010_bib0022","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jcf.2023.08.010_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2017.07.017","article-title":"Sexual And reproductive health behaviors and experiences reported by young women with cystic fibrosis","volume":"17","author":"Kazmerski","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.08.010_bib0024","unstructured":"Cancer TCPA. Cervical cancer screening in Canada: monitoring & evaluation of quality indicators. https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2019\/01\/Cervical-Cancer-Screen-Quality-Indicators-Report-2016-EN.pdf (2016). Accessed July 24 2023,."},{"key":"10.1016\/j.jcf.2023.08.010_bib0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1186\/1471-2458-13-1065","article-title":"Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study In The UK","volume":"13","author":"Dominiak-Felden","year":"2013","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.jcf.2023.08.010_bib0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCP.0000000000000244","article-title":"The Psychological Burden Of Cystic Fibrosis","volume":"22","author":"Quittner","year":"2016","journal-title":"Curr Opin Pulm Med"},{"issue":"2\u20133","key":"10.1016\/j.jcf.2023.08.010_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ypmed.2007.05.013","article-title":"Predictors of HPV vaccine acceptability: a theory-informed, systematic review","volume":"45","author":"Brewer","year":"2007","journal-title":"Prev Med"},{"issue":"9","key":"10.1016\/j.jcf.2023.08.010_bib0028","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.vaccine.2016.01.023","article-title":"Provider Communication And HPV Vaccination: the Impact Of Recommendation Quality","volume":"34","author":"Gilkey","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jcf.2023.08.010_bib0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ypmed.2013.10.009","article-title":"Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review","volume":"58","author":"Rambout","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/j.jcf.2023.08.010_bib0030","article-title":"Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18-35","volume":"29","author":"Muthukrishnan","year":"2022","journal-title":"Prev Med Rep"},{"issue":"3","key":"10.1016\/j.jcf.2023.08.010_bib0031","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpag.2020.12.004","article-title":"Human papilloma virus vaccination among female patients attending french pediatric cystic fibrosis centers","volume":"34","author":"Rousset-Jablonski","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"42","key":"10.1016\/j.jcf.2023.08.010_bib0032","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the united states","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.jcf.2023.08.010_bib0033","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.vaccine.2023.02.049","article-title":"Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States","volume":"41","author":"Clay","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jcf.2023.08.010_bib0034","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jama.2019.18411","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices (ACIP)","volume":"323","author":"Oshman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2023.08.010_bib0035","unstructured":"Public Health Agency of Canada. Human Papillomavirus Vaccine: canadian Immunization Guide. (2017). Accessed March 23 2023,."},{"issue":"41","key":"10.1016\/j.jcf.2023.08.010_bib0036","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: a systematic review and meta-analysis","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jcf.2023.08.010_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167173","article-title":"Seroprevalence and associated factors of 9-valent human papillomavirus (HPV) Types among Men in the Multinational HIM study","volume":"11","author":"Rahman","year":"2016","journal-title":"PLoS ONE"},{"issue":"7\u20138","key":"10.1016\/j.jcf.2023.08.010_bib0038","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/21645515.2018.1547607","article-title":"Examining strategies for improving healthcare providers' communication about adolescent HPV vaccination: evaluation of secondary outcomes in a randomized controlled trial","volume":"15","author":"Reno","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jcf.2023.08.010_bib0039","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amepre.2018.07.038","article-title":"Implementation of strategies to improve human papillomavirus vaccine coverage: a provider survey","volume":"56","author":"Walling","year":"2019","journal-title":"Am J Prev Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:32:11Z","timestamp":1777649531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323008792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1569199323008792"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and impact of human papillomavirus (HPV) in adults with cystic fibrosis: A self-reported cross-sectional Canadian survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}